Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Intranasal dexmedetomidine compositions and methods of use thereof

Intranasal dexmedetomidine compositions and methods of use thereof

US Patent 10682311 · Granted Jun 16, 2020

Estimated economic value: $2,430,000 ⓘ

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Modified peptide fragments of Cav-1 protein and the use thereof in the treatment2025
Formulation for soft anticholinergic analogs2025
Formulation for soft anticholinergic analogs2025
Dry powder formulation of caveolin-1 peptides and methods of use thereof2025
Dry powder formulation of caveolin-1 peptides and methods of use thereof2025
Formulation for soft anticholinergic analogs2024
Modified peptide fragments of CAV-1 protein and the use thereof in the treatment2024
Modified peptide fragments of CAV-1 protein and the use thereof in the treatment2023
Compositions, formulations and interleukin production and purification2022
Methods of administering intravenous meloxicam in a bolus dose2022
Compositions, formulations and interleukin production and purification2021
Formulation for soft anticholinergic analogs2021